Protagenic Therapeutics, Inc.\new annual revenue
2014
2015
2016
2020
2021
2022
2023
2024
2025
2026
Protagenic Therapeutics, Inc.\new Revenue Growth & History (PTIX)
Protagenic Therapeutics, Inc.\new reported $0 in revenue for fiscal 2026.
View full Protagenic Therapeutics, Inc.\new company overviewProtagenic Therapeutics, Inc.\new annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $0 | $0 | — |
| 2025 | 2025-03-31 | $0 | — | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | $0 | — |
| 2021 | 2021-12-31 | $0 | $0 | — |
| 2020 | 2020-12-31 | $0 | — | — |
| 2016 | 2016-12-31 | $0 | $0 | — |
| 2015 · Dec 31 | 2015-12-31 | $0 | — | — |
| 2014 | 2014-06-30 | $0 | — | — |
Protagenic Therapeutics, Inc.\new quarterly revenue
Q2.11
Q3.11
Q2.11
Q3.11
Q3.15
Q4.15
Q1.16
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q4 2026 | 2026-03-31 | $0 | $0 | — |
| Q3 2026 | 2025-12-31 | $0 | $0 | — |
| Q2 2026 | 2025-09-30 | $0 | $0 | — |
| Q1 2026 | 2025-06-30 | $0 | $0 | — |
| Q4 2025 | 2025-03-31 | $0 | $0 | — |
| Q4 2024 | 2024-12-31 | $0 | $0 | — |
| Q3 2024 | 2024-09-30 | $0 | $0 | — |
| Q2 2024 | 2024-06-30 | $0 | $0 | — |
| Q1 2024 | 2024-03-31 | $0 | $0 | — |
| Q4 2023 | 2023-12-31 | $0 | $0 | — |
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q2 2023 | 2023-06-30 | $0 | $0 | — |
| Q1 2023 | 2023-03-31 | $0 | $0 | — |
| Q4 2022 | 2022-12-31 | $0 | $0 | — |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q2 2022 | 2022-06-30 | $0 | $0 | — |
| Q1 2022 | 2022-03-31 | $0 | $0 | — |
| Q4 2021 | 2021-12-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q2 2021 | 2021-06-30 | $0 | — | — |
| Q1 2021 | 2021-03-31 | $0 | — | — |
| Q3 2020 | 2020-09-30 | $0 | — | — |
| Q3 2017 | 2017-09-30 | $0 | $0 | — |
| Q2 2017 | 2017-06-30 | $0 | $0 | — |
| Q1 2017 | 2017-03-31 | $0 | $0 | — |
| Q4 2016 | 2016-12-31 | $0 | $0 | — |
| Q3 2016 | 2016-09-30 | $0 | $0 | — |
| Q2 2016 | 2016-06-30 | $0 | $0 | — |
| Q1 2016 · Mar 31 | 2016-03-31 | $0 | $0 | — |
| Q4 2015 | 2015-12-31 | $0 | — | — |
| Q1 2016 · Sep 30 | 2015-09-30 | $0 | — | — |
| Q4 2015 · Jun 30 | 2015-06-30 | $0 | — | — |
| Q3 2015 | 2015-03-31 | $0 | — | — |
| Q3 2011 · Sep 30 | 2011-09-30 | $12.3M | $3.1M | +34.31% |
| Q2 2011 · Jun 30 | 2011-06-30 | $6.3M | −$4.5M | −42.01% |
| Q3 2011 · Sep 30 | 2010-09-30 | $9.2M | — | — |
| Q2 2011 · Jun 30 | 2010-06-30 | $10.8M | — | — |
Protagenic Therapeutics, Inc.\new revenue growth trends
Protagenic Therapeutics, Inc.\new's latest reported quarter, Q4 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Protagenic Therapeutics, Inc.\new source filings ↗